CompletedPhase 2NCT00006280
A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Principal Investigator
- Jeffrey Wagener, M.D.The Children's Hospital
- Intervention
- Tobramycin for Inhalation(drug)
- Enrollment
- 98 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2000 – 2002
Study locations (9)
- Stanford University/Lucille Packard Children's Health Services at Stanford, Palo Alto, California, United States
- The Children's Hospital, Denver, Colorado, United States
- Johns Hopkins Hospital, Baltimore, Maryland, United States
- Children's Hospital, Boston, Massachusetts, United States
- University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
- Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States
- Baylor College of Medicine, Houston, Texas, United States
- Children's Hospital and Regional Medical Center, Seattle, Washington, United States
Collaborators
National Center for Research Resources (NCRR)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00006280 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT04530383Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel FunctionUniversity of Kansas Medical Center
- RECRUITINGPHASE2NCT07450547Phase 2 Study to Assess the Safety and Efficacy of ANG003Anagram Therapeutics, Inc.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.